Patents by Inventor Barbara Podobnik

Barbara Podobnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing a composition of pegylated proteins
    Publication number: 20160058878
    Abstract: This invention is in the field of protein pegylation. In particular, it relates to a method for pegylating therapeutic proteins. The invention also relates to the use of such pegylated therapeutic polypeptides for treating muscle diseases and disorders.
    Type: Application
    Filed: December 11, 2014
    Publication date: March 3, 2016
    Applicant: NOVARTIS AG
    Inventors: Simona JEVSEVAR, Menci KUNSTELJ, Barbara PODOBNIK
  • Surfactant-free stable pharmaceutical composition comprising granulocyte-colony stimulating factor
    Patent number: 8580246
    Abstract: The present invention provides a new stable pharmaceutical composition of granulocyte-colony stimulating factor (G-CSF).
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: November 12, 2013
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Barbara Podobnik, Vladka Gaberc Porekar, Viktor Menart
  • Pharmaceutical composition comprising an active principal and sulphobetaine
    Patent number: 7906109
    Abstract: The present invention relates to the pharmaceutical composition comprising a non-detergent sulphobetaine (NDSB).
    Type: Grant
    Filed: December 22, 2004
    Date of Patent: March 15, 2011
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Viktor Menart, Vladka Gaberc Porekar, Barbara Podobnik
  • Stable Pharmaceutical Composition Comprising Granulocyte-Colony Stimulating Factor
    Publication number: 20100021419
    Abstract: The present invention provides a new stable pharmaceutical composition of granulocyte-colony stimulating factor (G-CSF).
    Type: Application
    Filed: September 4, 2009
    Publication date: January 28, 2010
    Applicant: LEK PHARMACEUTICALS D.D.
    Inventors: Barbara PODOBNIK, Vladka GABERC POREKAR, Viktor MENART
  • Stable pharmaceutical composition granulocyte-colony stimulating factor
    Patent number: 7585496
    Abstract: The present invention provides a new stable pharmaceutical composition of granulocyte-colony stimulating factor (G-CSF).
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: September 8, 2009
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Barbara Podobnik, Vladka Gaberc Porekar, Viktor Menart
  • Crystalline form of omeprazole
    Patent number: 7553856
    Abstract: A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: June 30, 2009
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Natasa H Milac, Anton Copar, Barbara Podobnik, Andreja C Belcic, Alenka Kosak, Brina Ornik, Uros Urleb
  • Pharmaceutical composition comprising an active principal and sulphobetaine
    Publication number: 20070184019
    Abstract: The present invention relates to the pharmaceutical composition comprising a non-detergent sulphobetaine (NDSB).
    Type: Application
    Filed: December 22, 2004
    Publication date: August 9, 2007
    Inventors: Viktor Menart, Vladka Gaberc Porekar, Barbara Podobnik
  • Stable pharmaceutical compostion comprising granulocyte-colony stimulating factor
    Publication number: 20070081971
    Abstract: The present invention provides a new stable pharmaceutical composition of granulocyte-colony stimulating factor (G-CSF).
    Type: Application
    Filed: November 4, 2003
    Publication date: April 12, 2007
    Inventors: Barbara Podobnik, Vladka Gaberc Porekar, Viktor Menart
  • Crystalline form of omeprazole
    Publication number: 20060079560
    Abstract: A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.
    Type: Application
    Filed: October 12, 2005
    Publication date: April 13, 2006
    Inventors: Natasa Milac, Anton Copar, Barbara Podobnik, Andreja Belcic, Alenka Kosak, Brina Ornik, Uros Urleb
  • Crystalline form of omeprazole
    Publication number: 20040122056
    Abstract: A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny] -1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.
    Type: Application
    Filed: October 17, 2003
    Publication date: June 24, 2004
    Inventors: Natasa Hafner Milac, Anton Copar, Barbara Podobnik, Andreja Cizerle Belcic, Alenka Kosak, Brina Ornik, Uros Urleb